RUV-27791-95823
4 vaccinations
7 coded responses
52 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 913 / CA
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
4D9-20278-78082
Child or adolescent in my care · Female · 2022-10-03
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
- 2021-03-15
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-05
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Good · Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-16
- 2021-07-02
- 2021-10-01
-
2021-12-08
Dose 3 — Pfizer-BioNTech
-
2021-12-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-13
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Good · Be unable to do your normal daily activitiesFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
- 2021-12-14
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-03-09
-
2022-06-08
Survey response — 6 months, dose 3MedDRA: COVID-19, Hernia, Unevaluable event — Feeling: Good · Be unable to do your normal daily activitiesFree text: COVID PPD HERNIAMedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Dose 4 — Moderna
- 2022-10-03
-
2022-10-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-05
-
2022-10-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-07
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2022-10-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-09
- 2022-10-12
-
2022-10-17
Survey response — day 14, dose 4MedDRA: Cough, Nasopharyngitis, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold , cough, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — day 14, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-18
-
2022-10-24
Survey response — day 21, dose 4MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, cold, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-11-07
-
2022-11-14
Survey response — day 42, dose 4MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: More headachesMedDRA releases: 2024-11 · check-in free text available
- 2023-01-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-03 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia
Systemic reaction (other): Insomnia
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Insomnia
Release 11 — 6 months, dose 3
Symptoms: COVID PPD HERNIA
Release 12 — day 14, dose 4
Symptoms: Cold , cough, fever
Release 12 — day 21, dose 4
Symptoms: Cough, cold, runny nose
Release 12 — day 42, dose 4
Symptoms: More headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hernia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release